Company Name: Recro Pharma, Inc.

Recro Pharma, Inc. is a specialty pharmaceutical company. The company is engaged in the development of non-opioid therapeutics designed to treat pain (acute postoperative pain initially). In addition, the company receives royalties associated with the sale of the commercial products manufactured in its owned/operated DEA-licensed facility.

Ticker Symbol: REPH (NASDAQ)

Company Website:

Headquarters: Malvern, Pennsylvania